Navigation Links
Varian, Inc. Board Authorizes New $100 Million Stock Repurchase Program
Date:2/11/2008

PALO ALTO, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today announced that its Board of Directors has authorized the repurchase of up to $100 million in shares of its common stock. The new repurchase program is effective until December 31, 2009.

"This share repurchase program is another example of our continued focus on capital allocation management to enhance long-term value for our shareholders," said G. Edward McClammy, Senior Vice President, Chief Financial Officer and Treasurer. "With the strength of our cash position, balance sheet and cash flow, we have the financial capacity to complete this repurchase authorization and continue our strategy of acquiring businesses that complement our existing product range."

Stock repurchases under this program may be made in the open market or in private transactions, at times and in amounts that management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price and regulatory requirements.

The Company's previous $100 million stock repurchase program, which was approved in January 2007 and effective until December 31, 2008, was completed in February 2008. Under that program, the Company repurchased 1,738,100 shares of its common stock, including 667,860 shares repurchased for $36.1 million in the current quarter. As of December 28, 2007, the Company had 30,430,249 common shares outstanding.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For Information Contact:

Investor Relations

Varian, Inc.

650.424.5471

ir@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Varian, Inc. CEO to Speak at JPMorgan Healthcare Conference
2. Varian, Inc. Acquires Analogix Business
3. Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides.
4. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
5. Brookdale Senior Living Announces Changes in Senior Management and Board of Directors
6. Former Navy Surgeon General Is Among Three New Accomplished TriWest Advisory Board Members
7. Lupus Foundation of America Launches Website Message Boards to Connect People With Lupus
8. ORBIS International Announces the Death of the Honorable Oliver Foot, President and Board Member
9. AtriCure Appoints Mark A. Collar to its Board of Directors
10. Survey Reveals Most Pet Owners Consider Kennel Boarding a Necessary Evil; Pet Care Industry Shortcomings Spawn Improved Approach
11. Staples Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Houston dentist , ... office, Antoine Dental Center. Currently, patients can get single dental implants for $3,599 ... patients can learn more about these offers by contacting Antoine Dental Center. Both ...
(Date:2/24/2017)... ... ... An in-depth computational analysis of genetic variants implicated in both schizophrenia and rheumatoid ... explain why susceptibility to one of the disorders could place individuals at lower risk ... journal npj Schizophrenia. , “There is a wealth of genomic data on both ...
(Date:2/24/2017)... ... February 24, 2017 , ... In the Health Care IT campaign, Robert Herjavec ... it’s not if you will be attacked, but when.” However, he and many others ... health care. , Improvements in auditing and monitoring have taken security in health care ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Yisrayl Hawkins, ... focuses on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement ... current generation. He explains that the Bible details the current times so plainly ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 ITL Limited, ( ASX: ITD ), ... for the half year ended 31 December 2016 compared with the ... presentation can be viewed here . Highlights ... $1.04m; up 104%) Earnings per share of 2.2 ... of $17.5m (Dec 2015: $15.7m; up 11%) Profit ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
(Date:2/23/2017)... 23, 2017 Obese people are ... for varicose veins in their body. The rising number ... the adoption of endovenous laser therapy for treatment of ... laser therapy market, published by Future Market Insights, ... and consequences of obesity have collectively factored the growth ...
Breaking Medicine Technology: